RBC Capital on Chemours (CC): 'we continue to expect CC's APM portfolio transformation from AM to PS to drive stability'
Tweet Send to a Friend
RBC Capital analyst Arun Viswanathan reiterated an Outperform rating and $21.00 price target on Chemours (NYSE: CC).The analyst comments "Overall ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
